These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20403084)

  • 1. Mice lacking p35 display hyperactivity and paradoxical response to psychostimulants.
    Krapacher FA; Mlewski EC; Ferreras S; Pisano V; Paolorossi M; Hansen C; Paglini G
    J Neurochem; 2010 Jul; 114(1):203-14. PubMed ID: 20403084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35.
    Drerup JM; Hayashi K; Cui H; Mettlach GL; Long MA; Marvin M; Sun X; Goldberg MS; Lutter M; Bibb JA
    Biol Psychiatry; 2010 Dec; 68(12):1163-71. PubMed ID: 20832057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient enhanced expression of Cdk5 activator p25 after acute and chronic d-amphetamine administration.
    Mlewski EC; Krapacher FA; Ferreras S; Paglini G
    Ann N Y Acad Sci; 2008 Oct; 1139():89-102. PubMed ID: 18991853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice.
    Beaulieu JM; Sotnikova TD; Gainetdinov RR; Caron MG
    J Biol Chem; 2006 Oct; 281(43):32072-80. PubMed ID: 16954211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Cdk5 activity is involved on Dopamine Transporter expression and function: Evidences from an animal model of Attention-Deficit Hyperactivity Disorder.
    Fernández G; Krapacher F; Ferreras S; Quassollo G; Mari MM; Pisano MV; Montemerlo A; Rubianes MD; Bregonzio C; Arias C; Paglini MG
    Exp Neurol; 2021 Dec; 346():113866. PubMed ID: 34537209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the expression of amphetamine-induced behavioral sensitization and Cdk5/p35 activity in dorsal striatum.
    Mlewski EC; Arias C; Paglini G
    Behav Neurosci; 2016 Feb; 130(1):114-22. PubMed ID: 26692451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
    Del'Guidice T; Lemasson M; Etiévant A; Manta S; Magno LA; Escoffier G; Roman FS; Beaulieu JM
    Psychopharmacology (Berl); 2014 Jan; 231(1):109-22. PubMed ID: 23912772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
    Gainetdinov RR; Wetsel WC; Jones SR; Levin ED; Jaber M; Caron MG
    Science; 1999 Jan; 283(5400):397-401. PubMed ID: 9888856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2.
    Smith PD; Mount MP; Shree R; Callaghan S; Slack RS; Anisman H; Vincent I; Wang X; Mao Z; Park DS
    J Neurosci; 2006 Jan; 26(2):440-7. PubMed ID: 16407541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
    Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
    J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
    Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate.
    Keck TM; Suchland KL; Jimenez CC; Grandy DK
    Pharmacol Biochem Behav; 2013 Feb; 103(4):831-41. PubMed ID: 23262298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.
    Ohshima T; Ogawa M; Veeranna ; Hirasawa M; Longenecker G; Ishiguro K; Pant HC; Brady RO; Kulkarni AB; Mikoshiba K
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2764-9. PubMed ID: 11226314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology.
    Meyer DA; Richer E; Benkovic SA; Hayashi K; Kansy JW; Hale CF; Moy LY; Kim Y; O'Callaghan JP; Tsai LH; Greengard P; Nairn AC; Cowan CW; Miller DB; Antich P; Bibb JA
    Proc Natl Acad Sci U S A; 2008 Nov; 105(47):18561-6. PubMed ID: 19017804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5.
    Paoletti P; Vila I; Rifé M; Lizcano JM; Alberch J; Ginés S
    J Neurosci; 2008 Oct; 28(40):10090-101. PubMed ID: 18829967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants.
    Corvol JC; Valjent E; Pascoli V; Robin A; Stipanovich A; Luedtke RR; Belluscio L; Girault JA; Hervé D
    Neuropsychopharmacology; 2007 May; 32(5):1109-21. PubMed ID: 17063155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diacylglycerol kinase β knockout mice exhibit attention-deficit behavior and an abnormal response on methylphenidate-induced hyperactivity.
    Ishisaka M; Kakefuda K; Oyagi A; Ono Y; Tsuruma K; Shimazawa M; Kitaichi K; Hara H
    PLoS One; 2012; 7(5):e37058. PubMed ID: 22590645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.
    Carli M; Kostoula C; Sacchetti G; Mainolfi P; Anastasia A; Villani C; Invernizzi RW
    J Neurochem; 2015 Nov; 135(4):674-85. PubMed ID: 26259827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-Deficit/Hyperactivity Disorder-like Phenotype in a Mouse Model with Impaired Actin Dynamics.
    Zimmermann AM; Jene T; Wolf M; Görlich A; Gurniak CB; Sassoè-Pognetto M; Witke W; Friauf E; Rust MB
    Biol Psychiatry; 2015 Jul; 78(2):95-106. PubMed ID: 24768258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.